The high incidence of 96,922 new cervical cancers diagnosed annually in Indian women contributes significantly to the global burden of cervical cancers. Cervical Cancers are caused by High Risk Human Papilloma Virus (HR-HPV) and 99.7% are positive for HR-HPV. The good news is that Cervical Cancer is preventable through HPV Vaccination and systematic, organized HPV screening, leading to prevention and early detection resulting in better prognosis and high rate of cure with systematically organised cervical cancer screening.
CPAA is focused on application of triple strategy for elimination of cervical cancer from India. These comprise:
CPAA holds interactive sessions highlighting the risk factors, modalities of prevention and early detection and signs/symptoms of cervical cancer, and removal of the myths, misconceptions, fear and stigma associated with cervical cancer.
CPAA provides international state-of-the-art Hybrid Capture 2 testing facility for high risk HPVs at the Mumbai Center. The test detects clinically relevant HR-HPVs indicating risk of cervical cancer in Indian women. Initiatives to provide free HPV tests for the socio-economically underprivileged women and subsidized rates for women for screening for cervical cancer mark the cancer screening tests.
At any given time, about 6.6% of women in India have cervical HPV infection. HPV 16 and 18 account for 70% - 80% cervical cancers in India. Two HPV vaccines are available in India, as Gardasil and Cervarix. These vaccines are prophylactic in nature and should be prior to HPV infection.
CPAA has initiated several free HPV Vaccination Camps for girl students from marginalised socio-economic background in villages of Maharashtra with generous sponsorships from corporate groups. CPAA was invited by Chief Minister's Health Mission Cell, Mantralaya, Maharashtra, to conduct the HPV vaccination camps in Dindrud, Ahmednagar, in Vairag, Solapur and Ralegaon Siddhi, Ahmednagar (mentored by Social Activist Shri Anna Hazare). Two doses of the vaccine were administered to 1,500 school girls. At Ralegaon Siddhi women in the age group 26 - 45 years, the women were screened for HPV using the Hybrid Capture 2 System. The screening and vaccination will result in reducing the incidence of cervical cancers, downgrade the cancer, and better prognosis in cervical cancer in the Indian women.
Support CPAA's Cervical Cancer Screening Program:
CPAA’s Cervical Cancer Vaccination Program:
|Recommended Vaccination Schedule|
|Age||9 -14 years||15 - 26 years||26 - 45 years|
|Dosage||2 Doses (at 0 & 6 months)||3 Doses (at 0, 1 & 6 months)||3 Doses (at 0, 1 & 6 months) (HPV Screening recommended prior to vaccination of this group)|
(Help us keep you updated of our projects with an email about your generous donation)